Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07579234 Recombinant humanized anti-BCMA/CD3 bispecific antibody(Shandong New Time Pharma Refractory Multiple Myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07579234 clinical trial report covering Recombinant humanized anti-BCMA/CD3 bispecific antibody(Shandong New Time Pharma, Phase 3, endpoints, sponsor, geog
Latest Hotspot
8 min read
NCT07582432 Immune Globulin (Human)(Grifols) Secondary Antibody Deficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07582432 clinical trial report covering Immune Globulin (Human)(Grifols), Phase 3, endpoints, sponsor, geography, readout timing and development white spac
Latest Hotspot
8 min read
JPRN-jRCT2071260025 Cenobamate Epilepsies, Partial Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
JPRN-jRCT2071260025 clinical trial report covering Cenobamate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07581951 HSK-31679 Metabolic Dysfunction Associated Steatohepatitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07581951 clinical trial report covering HSK-31679, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07582315 Izalontamab Brengitecan Biliary Tract Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07582315 clinical trial report covering Izalontamab Brengitecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07579351 Dexamethasone Sodium Phosphate Radicular Pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07579351 clinical trial report covering Dexamethasone Sodium Phosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261878 Recombinant Zoster Vaccine(CHO Cell)(Kangtai) Herpes Zoster Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261878 clinical trial report covering Recombinant Zoster Vaccine(CHO Cell)(Kangtai), Phase 3, endpoints, sponsor, geography, readout timing and developme
Latest Hotspot
8 min read
CTR20261818 C-019199 Osteosarcoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261818 clinical trial report covering C-019199, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07584525 Dexamethasone Encephalitis, Tick-Borne Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07584525 clinical trial report covering Dexamethasone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07582549 Amoxicillin Trihydrate Persistent cough Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07582549 clinical trial report covering Amoxicillin Trihydrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07583849 HSK-39004 Pulmonary Disease, Chronic Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07583849 clinical trial report covering HSK-39004, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20261797 Citric Acid/Urea C-13 Helicobacter pylori infection Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20261797 clinical trial report covering Citric Acid/Urea C-13, Phase 3, endpoints, sponsor, geography, readout timing and development white space.